SAB Biotherapeutics, Inc.(SABS)
Biotechnology
Immunology & Autoimmune Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-12-08 | Sullivan Eddie Joe Chief Executive Officer | Purchase | +1,740 | +0.03%5,232,304 | $0.88 | $1,531 | View SEC filing | |
| 2023-11-30 | King Michael CHIEF FINANCIAL OFFICER | Purchase | +5,000 | +100.00%5,000 | $0.90 | $4,500 | View SEC filing | |
| 2023-11-30 | Reich Samuel J Executive Chairman | Purchase | +11,000 | +5.29%219,001 | $0.89 | $9,842 | View SEC filing | |
| 2022-09-14 | HAMILTON CHRISTINE E Director, 10% Owner | Purchase | +10,000 | +0.20%4,993,090 | $0.73 | $7,297 | View SEC filing | |
| 2022-09-08 | Sullivan Eddie Joe CHIEF EXECUTIVE OFFICER | Purchase | +14,000 | +0.27%5,230,564 | $0.74 | $10,315 | View SEC filing | |
| 2021-11-16 | Beyer Russell P Chief Financial Officer | Sale | -278 | -100.00%0 | $7.90 | $2,196 | View SEC filing | |
| 2021-10-15 | Katz Ilan Director, 10% Owner | Purchase | +500 | +50.00%1,500 | $10.11 | $5,053 | View SEC filing | |
| 2021-10-15 | Reich Samuel J CEO and CFO | Purchase | +1,000 | +100.00%1,000 | $10.11 | $10,110 | View SEC filing | |
| 2021-10-05 | Spragens Jeffrey G Director | Purchase | +13,000 | +100.00%13,000 | $10.07 | $130,910 | View SEC filing | |
| 2021-10-05 | Katz Ilan Director, 10% Owner | Purchase | +1,000 | +100.00%1,000 | $10.09 | $10,090 | View SEC filing | |
| 2021-01-14 | Reich Samuel J CEO and CFO | Purchase | +417,200 | +15.86%3,047,825 | $10.00 | $4,172,000 | View SEC filing | |
| 2021-01-14 | Katz Ilan Director, 10% Owner | Purchase | +417,200 | +15.86%3,047,825 | $10.00 | $4,172,000 | View SEC filing | |
| 2021-01-14 | Big Cypress Holdings LLC CEO and CFO | Purchase | +417,200 | +15.86%3,047,825 | $10.00 | $4,172,000 | View SEC filing |
1-13 of 13